Treat to Target Trial in Axial Spondylo Arthritis : The TICOSPA (Tight Control in Spondyloarthritis)
NCT03043846 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 163
Last updated 2019-09-27
Summary
This is a not interventional, pragmatic, prospective, randomized (cluster) study to evaluate the potential benefit of a Treat to Target approach in comparison to routine treatment (i.e. usual care) in patients with axial spondyloarthritis.
Conditions
- Axial Spondyloarthritis
Interventions
- OTHER
-
Follow-up every 3 months during 1 year (data collection in eCRF)
- OTHER
-
Follow-up every month to follow the pre-defined strategy
Sponsors & Collaborators
-
RCTs
collaborator INDUSTRY -
Association de Recherche Clinique en Rhumatologie
lead OTHER
Eligibility
- Min Age
- 18 Years
- Max Age
- 65 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2016-11-30
- Primary Completion
- 2019-06-18
- Completion
- 2019-06-18
Countries
- Belgium
- France
- Netherlands
Study Locations
More Related Trials
-
A Study of RoActemra/Actemra (Tocilizumab) Given Subcutaneously in Combination With Traditional DMARDs in Patients With Moderate to Severe Active Rheumatoid Arthritis
NCT01232569 ·Status: COMPLETED ·Phase: PHASE3
-
A Study to Evaluate the Efficacy and Safty of 608 in Patients With Non- Radiographic Axial Spondyloarthritis (Nr-axSpA)
NCT07349329 ·Status: NOT_YET_RECRUITING ·Phase: PHASE3
-
A Study to Evaluate the Use of Glucocorticoids in Combination With Tocilizumab in Daily Clinical Practice
NCT03291457 ·Status: COMPLETED
-
An Observational Study of RoActemra/Actemra (Tocilizumab) in Rheumatoid Arthritis Patients
NCT01615419 ·Status: COMPLETED
-
An Observational Study of Tocilizumab (Actemra) in Participants With Moderate to Severe Rheumatoid Arthritis
NCT01741688 ·Status: COMPLETED
-
Evaluation of a Protocol for Dose Reduction in Patients With Spondylarthropathies and Clinical Remission With Anti-TNF
NCT01604629 ·Status: COMPLETED ·Phase: PHASE4
-
An Observational Study on RoActemra/Actemra (Tocilizumab) in Clinical Practice in Patients With Rheumatoid Arthritis (TRUST)
NCT01394276 ·Status: COMPLETED
-
A Study of Brodalumab in Subjects With Axial Spondyloarthritis (axSpA)
NCT02985983 ·Status: COMPLETED ·Phase: PHASE3
-
A Non-Interventional Study of RoActemra/Actemra (Tocilizumab) in Patients With Moderate to Severe Rheumatoid Arthritis
NCT01670045 ·Status: COMPLETED
-
A Study of SPY072 in Rheumatic Disease
NCT07148414 ·Status: RECRUITING ·Phase: PHASE2
-
Initial Standardized Global Review in Axial Spondyloarthritis
NCT07141017 ·Status: RECRUITING ·Phase: NA
-
Efficacy of NNC109-0012 in Subjects With Active Rheumatoid Arthritis
NCT01282255 ·Status: COMPLETED ·Phase: PHASE2
-
Uncontrolled Study to Evaluate Efficacy of Tocilizumab in Patients With Moderate or Severe Rheumatoid Arthritis
NCT02087696 ·Status: UNKNOWN ·Phase: PHASE4
-
A Prospective, Non-Interventional Study of RoActemra/Actemra (Tocilizumab) in Patients With Moderate to Severe Active Rheumatoid Arthritis
NCT01770834 ·Status: COMPLETED
-
Study to Compare the Efficacy of Tocilizumab With or Without Glucocorticoid Discontinuation in Rheumatoid Arthritis Participants
NCT02573012 ·Status: COMPLETED ·Phase: PHASE4
-
Abatacept vs Tocilizumab for the Treatment of RA in TNF Alpha Inhibitor Inadequate Responders
NCT03227419 ·Status: UNKNOWN ·Phase: PHASE4
-
A Study to Assess Efficacy With Respect to Clinical Improvement in Disease Activity and Safety of Tocilizumab in Patients Wtih Active Rheumatoid Arthritis.
NCT00754559 ·Status: COMPLETED ·Phase: PHASE3
-
A Study of RoActemra/Actemra (Tocilizumab) in Combination With DMARDs Versus Current Best Practice DMARD Therapy in Patients With Rheumatoid Arthritis
NCT01251120 ·Status: TERMINATED ·Phase: PHASE4
-
A Prospective Observational Study of Tocilizumab (RoActemra/Actemra) in Participants With Rheumatoid Arthritis
NCT01462162 ·Status: COMPLETED
-
Rotation or Change of Biotherapy After TNF Blocker Treatment Failure for Axial Spondyloarthritis
NCT03445845 ·Status: COMPLETED ·Phase: PHASE4
-
Patient-Reported Outcomes In Rheumatoid Arthritis Patients Treated With Tofacitinib Or Biological Disease-Modifying Antirheumatic Drugs (DMARDs) In Real Life Conditions
NCT03073109 ·Status: COMPLETED
-
A Study to Investigate Efficacy, Tolerability and Safety of ABY-035 in Patients With Active Psoriatic Arthritis
NCT04713072 ·Status: COMPLETED ·Phase: PHASE2
-
An Observational Study of RoActemra/Actemra in Patients With Moderate to Severe Rheumatoid Arthritis
NCT01375478 ·Status: COMPLETED
-
Atacicept in Combination With Rituximab in Subjects With Rheumatoid Arthritis (August III)
NCT00664521 ·Status: COMPLETED ·Phase: PHASE2
-
A Study to Assess the Effectiveness of Certolizumab Pegol in Patients With Axial Spondyloarthritis in Daily Life
NCT02354105 ·Status: COMPLETED